TruthArchive.ai - Related Video Feed

Dr. Hotez explains that while vaccines are often described as miraculous, the development was not a four-month process but a seventeen-year effort dating back to the post-SARS period. After SARS emerged in 2003, researchers identified the spike protein as the virus’s soft underbelly and began experimental vaccine development. When the COVID-19 sequence was released in January, the coronavirus community quickly concluded that a vaccine could be made, and attention turned to which technology would be fastest and most enduring. All vaccines discussed (AstraZeneca, Pfizer, Moderna, J&J, and the one being scaled in India) target the spike protein. He emphasizes that this was a deliberate long-term program, not a rushed push. Nicole notes the broader context of vaccine safety, particularly on a day when a vaccine-skeptical witness testified before the Senate Homeland Security Committee. Dr. Hotez clarifies that the virus behind the current pandemic comes from a family of coronaviruses scientists have studied for a long time, and that once specifics emerged, researchers could finalize the vaccine approach. He reiterates the importance of reassurance about safety in light of public skepticism. Dr. Hotez highlights the role of the NIH and the National Institute of Allergy and Infectious Diseases, led by Tony Fauci, and Francis Collins at NIH, in launching a major coronavirus program beginning in 2003. This funding enabled the development of some of the first prototype vaccines, illustrating a deliberate US government and NIH investment to advance vaccine research. He notes the ongoing need to assess rollout and production robustness, as this technology is brand new, and additional vaccines will be necessary to vaccinate populations. Looking ahead, the conversation acknowledges that the United States will require four or five different vaccines to achieve broad vaccination coverage, rather than relying solely on the two mRNA vaccines. The UK has begun vaccinations, marking an initial step, with plans to scale in the United States in the coming days. The discussion underscores a long road ahead to ensure scalable production, distribution, and multiple vaccine options to meet demand.

In a Phase one trial, a normal volunteer tests the safety of a potential vaccine. This process has been completed at a record speed. However, it will still take a few months to confirm its initial safety. The next step is a Phase two trial, involving hundreds or even thousands of people, which will take an additional 6 to 8 months to determine if the vaccine is effective. Overall, it will take around a year to a year and a half to know if the vaccine can be used. Another important aspect is ensuring that the vaccine does not worsen the infection. This can only be determined through extended studies involving individuals at risk. Previous cases have shown that vaccines that initially appeared safe actually made the situation worse. Therefore, caution is necessary before administering the vaccine.

The speaker emphasizes the lengthy process of developing a safe and effective vaccine, usually taking 10 to 25 years. They mention a potential safety issue with coronavirus vaccines, where immunization may lead to immune enhancement when exposed to the virus. This phenomenon has been observed in laboratory animals. Despite this concern, the speaker expresses enthusiasm for the approval of the second vaccine, stating that if enough Americans get vaccinated, virus transmission could be halted. They also mention the availability of new boosters, recommending anyone who is safe to get them for added protection.

People in America are hesitant to get vaccinated due to the lack of clear information and the speed at which the vaccine was developed. However, one person points out that it used to take years to develop vaccines, but now it can be done in a shorter time frame. Another person argues that nine months is not enough time to trust a vaccine that was created so quickly. The importance of vaccination is emphasized, as it can help stop the spread of the virus. The comparison is made between COVID-19 and the flu, with COVID-19 being seen as more serious due to the higher number of deaths. The conversation ends with one person expressing skepticism about the incentives and fear tactics used to promote vaccination.

Scientists are increasingly skeptical about the feasibility and safety of developing an AIDS vaccine. The concern lies in the lengthy testing process required to ensure its effectiveness and potential risks. Initially, a small group of individuals would be administered the vaccine, and if no adverse effects are observed after a year, it would be expanded to 500 people. After another year without complications, the vaccine would be given to thousands. However, the worry is that it could take up to 12 years for any serious issues to arise. This uncertainty raises doubts about the viability of creating an AIDS vaccine.

The COVID-19 vaccines have proven to be highly effective in the real world. Both the mRNA vaccine and another vaccine have shown efficacy rates of 94% to 95% for mild to moderate disease. In fact, the real world effectiveness of these vaccines is even more impressive than the results of the clinical trials. It is clear that these vaccines are highly effective in preventing COVID-19.

Trump gave Moderna's COO a billion-dollar check to develop a vaccine quickly, bypassing FDA regulations. Human trials began after testing on mice. Many doubted the speed and safety of the process, but the vaccine was developed in 6 months. Concerns were raised by vaccine experts about the rushed development.

Developing an effective and safe vaccine takes around 10 to 25 years, with the current record in the US being 3 to 4 years. The timeline for COVID-19 vaccines follows a similar progression as other vaccines. There are some minor differences, but overall, the development cycle is similar. It's important for people to understand this if they have concerns about taking COVID-19 vaccines.

Scientists are increasingly skeptical about the feasibility and safety of developing an AIDS vaccine. The concern lies in the lengthy testing process required to ensure its effectiveness and safety. Initially, a small group of individuals would receive the vaccine, and if no adverse effects are observed after a year, it would be administered to 500 people. If another year passes without any issues, the vaccine would be given to thousands. However, the worry is that it could take up to 12 years for serious problems to arise. This uncertainty raises questions about the viability of creating an AIDS vaccine.

There have been no concerning long-term side effects of the vaccine so far. The vaccine has only been in use for about a year, and we haven't seen any alarming issues with other vaccines that have been used for a long time. While we can't say for certain what might happen after several years, there is no scientific reason to believe that problems would suddenly arise. Although the vaccine is new, we have no plausible reason to expect any issues in the future.

Vaccines are seen as magical, but expectations may need to be lowered. Pfizer's vaccine is 95% effective, but efficacy rates can fluctuate. Protection may only last a year, requiring annual shots. Moderna is working on a combined flu and COVID vaccine. The future is uncertain, but there is hope for improvement in the next 5 years.

Safe and effective vaccines have been developed and millions of doses are being delivered. The vaccines have been rigorously studied and proven to be safe and effective. Researchers have confirmed the safety and efficacy of various vaccines, including the Oxford AstraZeneca and Pfizer COVID-19 vaccines. Vaccination has been deemed safe and effective for children, with Pfizer's vaccine being 100% effective for kids aged 5 to 11. The European Medicines Agency has thoroughly assessed the vaccines and concluded they are safe and effective against COVID-19. The vaccines have undergone extensive testing and have been found to be extremely safe and effective. Overall, vaccines are considered safe, effective, and free.

The most urgent invention is a COVID-19 vaccine, which teaches the immune system about the pathogen, specifically the coronavirus and its spike protein. The spike protein grabs cells and causes them to make billions of copies of the virus. Vaccines expose the body to something that looks like the virus, prompting the body to create antibodies to kill it. Vaccine creation usually involves injecting part of the virus's shape. This can be the whole virus, attenuated, or killed. Often, just a piece of the virus or the spike is used, eliminating the risk of causing disease. A promising new method is the RNA vaccine, which uses instructions to make the spike's shape. The Gates Foundation and partners are exploring these efforts. Creating a new vaccine typically takes at least 5 years, but there is optimism that a vaccine will be available in the next 18 months, produced in volume, and accessible worldwide, which will end the pandemic.

We are generating real-time data on mRNA vaccines, which have been in development for years due to side effects. Pfizer and Moderna used the pandemic to accelerate their development. The collaboration with BioNTech on flu led to the quick rollout of the mRNA vaccine. Clinical trials skipped phases, causing uncertainty. Concerns arise about vaccine distribution and the need for booster shots. Politics play a role in decision-making.

Developing a safe and effective vaccine typically takes 10 to 25 years, with the fastest in the US being around 3 to 4 years. The timeline for COVID-19 vaccines is similar to other vaccines, with some minor differences. This should reassure those hesitant about getting vaccinated.

The most urgent invention is a COVID-19 vaccine, which teaches the immune system about the pathogen, specifically the coronavirus and its spike protein. The spike protein grabs cells and causes them to make billions of copies of the virus. Vaccines expose the body to something that looks like the virus, prompting the body to create antibodies to kill it. Vaccine creation usually involves injecting part of the virus's shape. This can be the whole virus, attenuated, or killed, or just a piece of the virus or the spike. A promising new method is the RNA vaccine, which uses RNA and DNA to provide instructions to make the spike shape. The Gates Foundation and partners are exploring these efforts. Creating a new vaccine typically takes at least 5 years, but there is optimism that a vaccine will be available in the next 18 months, produced in volume, and accessible to everyone, which is how the pandemic will end.

I've been involved in over 50 vaccines, including mRNA vaccines. mRNA is like DNA, giving cells instructions to make proteins. This technology was originally for gene therapy, now used for vaccines. It's a new, experimental technology never used in humans before COVID. Animal studies were skipped for COVID vaccines, a novel approach.

The White House blames a few bad actors for spreading online misinformation. They say that misinformation on social media is harmful and can have long-term consequences. Developing a safe and effective vaccine takes time, usually around 10 to 25 years, and requires thorough clinical testing. The timeline for COVID-19 vaccines is similar to that of other vaccines.

Developing a vaccine is crucial to controlling the pandemic. Normally, it takes about five years to create a new vaccine, including testing for safety and effectiveness. However, efforts are being made to compress this timeline to around 18 months. The RNA platform shows promise in speeding up production. Ensuring a vaccine's effectiveness and safety, especially for older individuals, is challenging. We must avoid compromising safety while increasing efficacy. Decision-making regarding the use of a new vaccine will be based on limited data to expedite progress. Supporting the development of the most promising candidates, building production facilities, and conducting safety testing require a global collaborative effort. Our foundation is heavily involved in funding vaccines, including for developing countries. It's encouraging to see various medications emerging, such as Moderna, CureVac, Stamovi, and Logovac, which require investment.

People in America are skeptical about the information surrounding vaccinations, especially given the rapid development of COVID-19 vaccines. It traditionally takes years to create vaccines, and many feel that nine months isn't sufficient for safety. The conversation highlights the concern that unvaccinated individuals could allow the virus to spread further. While some compare COVID-19 to the flu, the death toll from COVID-19 significantly surpasses that of the flu in recent years. There are suspicions about the motives behind incentivizing vaccinations, suggesting that fear tactics are being used to encourage compliance. Ultimately, the pandemic is perceived by some as driven by fear rather than genuine health concerns.

It is important to consult with your doctor or a trusted person to understand the risks and frequency of side effects associated with vaccination. While these side effects do exist, they are very rare and mostly mild. Within 48 hours of vaccination, one may experience a headache or a slight fever. With this information, we can have confidence in the vaccination process.

The most urgent invention is a COVID-19 vaccine, which teaches the immune system about the pathogen, specifically the coronavirus and its spike protein. The spike protein grabs cells and causes them to make billions of copies of the virus. Vaccines expose the body to something that looks like the virus, prompting the body to create antibodies to kill it. Vaccine creation usually involves injecting part of the virus's shape. This can be the whole virus (attenuated), a killed virus, or just a piece of the virus, like the spike. A promising new method is the RNA vaccine, which uses instructions to make the spike's shape. The Gates Foundation and partners are exploring these efforts. Creating a new vaccine typically takes at least 5 years, but there is optimism that a vaccine will be available in the next 18 months, produced in volume, and accessible worldwide, which is how the pandemic will end.

Big companies said it wasn't possible, but Trump gave Moderna's COO $1 billion to develop a vaccine quickly. They started human trials after testing on mice. Many were skeptical, but the vaccine was ready in 6 months. Some experts raised concerns about the rushed development process.

We developed vaccines, like the Ameila vaccine, in just nine months. It's fast, considering the uncertainties surrounding vaccines. Initially, we made a mistake by claiming they protect against transmission, but they actually provide limited protection. As a result, repeated vaccinations are necessary due to their relatively short lifespan.

The rapid development of COVID-19 vaccines is unprecedented, but safety has not been compromised. The FDA is streamlining processes without cutting corners. Vaccines are being delivered in anticipation of approval to ensure readiness. Many are concerned about the speed of development, but the science is sound, and the vaccines are safe. As a healthcare worker, I received my vaccination without any issues, and my colleagues reported similar experiences. The vaccines show a 95% efficacy rate with minimal side effects. There are no long-term side effects reported so far. The feeling of getting vaccinated is liberating, signaling hope for the future. However, some public figures, like Wendy Williams, express skepticism about the vaccine, which could influence others negatively.